Page last updated: 2024-08-17

uridine triphosphate and zaprinast

uridine triphosphate has been researched along with zaprinast in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Champion, HC; Kadowitz, PJ1
Bivalacqua, TJ; Champion, HC; Kadowitz, PJ; Shah, MK1
Kadowitz, PJ; Shah, MK1

Other Studies

3 other study(ies) available for uridine triphosphate and zaprinast

ArticleYear
Vasodilator responses to ATP and UTP are not dependent on nitric oxide release, K+(ATP) channel activation, or the release of vasodilator prostaglandins in the hindlimb vascular bed of the cat.
    Canadian journal of physiology and pharmacology, 2000, Volume: 78, Issue:8

    Topics: Adenosine Triphosphate; Animals; Cats; Cyclic AMP; Dose-Response Relationship, Drug; Female; Hindlimb; Male; Nitric Oxide; Nitric Oxide Synthase; Phentolamine; Potassium Channels; Prostaglandins; Purinones; Reserpine; Uridine Triphosphate; Vasodilation

2000
Vasodilator responses to ATP and UTP are cAMP dependent in the mesenteric vascular bed of the cat.
    Journal of cardiovascular pharmacology and therapeutics, 2001, Volume: 6, Issue:3

    Topics: Adenosine Triphosphate; Animals; Cats; Cyclic AMP; Dose-Response Relationship, Drug; Female; Male; Meclofenamic Acid; NG-Nitroarginine Methyl Ester; Nitric Oxide; Purinones; Rolipram; Splanchnic Circulation; Thionucleotides; Uridine Triphosphate; Vasodilation

2001
Cyclic adenosine monophosphate-dependent vascular responses to purinergic agonists adenosine triphosphate and uridine triphosphate in the anesthetized mouse.
    Journal of cardiovascular pharmacology, 2002, Volume: 39, Issue:1

    Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Adenosine Triphosphate; Anesthesia; Animals; Blood Pressure; Cyclic AMP; Cyclooxygenase Inhibitors; Enzyme Inhibitors; Meclofenamic Acid; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide; Phosphodiesterase Inhibitors; Purinergic P2 Receptor Antagonists; Purinones; Pyridoxal Phosphate; Receptors, Purinergic P2; Rolipram; Uridine Triphosphate; Vasodilation

2002